BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2545980)

  • 1. [Chronic fatigue syndrome associated with Epstein-Barr virus infection].
    Parras F; Salvá F; Reina J; Gil J; Portela D; Alomar P
    Med Clin (Barc); 1989 Apr; 92(16):619-22. PubMed ID: 2545980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Viral infection and its causative role for chronic fatigue syndrome].
    Okano M
    Nihon Rinsho; 1992 Nov; 50(11):2617-24. PubMed ID: 1337559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of Epstein-Barr virus infections in human pathology].
    Vujosević M; Gvozdenović E
    Med Pregl; 1994; 47(11-12):393-7. PubMed ID: 7476696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic fatigue syndrome and virus infection: human herpesvirus 6 (HHV-6) infection].
    Yamanishi K
    Nihon Rinsho; 1992 Nov; 50(11):2612-6. PubMed ID: 1337558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [EBV diseases].
    Weber J
    Monatsschr Kinderheilkd; 1986 Feb; 134(2):60-6. PubMed ID: 3010085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease.
    Kikuta H; Taguchi Y; Tomizawa K; Kojima K; Kawamura N; Ishizaka A; Sakiyama Y; Matsumoto S; Imai S; Kinoshita T
    Nature; 1988 Jun; 333(6172):455-7. PubMed ID: 2836734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epstein-Barr virus infection--clinical aspects and diagnosis].
    Ernberg I; Andersson J; Linde A
    Nord Med; 1990; 105(1):19-23. PubMed ID: 2153950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome.
    Lerner AM; Dworkin HJ; Sayyed T; Chang CH; Fitzgerald JT; Beqaj S; Deeter RG; Goldstein J; Gottipolu P; O'Neill W
    In Vivo; 2004; 18(4):417-24. PubMed ID: 15369178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral serologies in patients with chronic fatigue and chronic fatigue syndrome.
    Buchwald D; Ashley RL; Pearlman T; Kith P; Komaroff AL
    J Med Virol; 1996 Sep; 50(1):25-30. PubMed ID: 8890037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome.
    Jones JF; Williams M; Schooley RT; Robinson C; Glaser R
    Arch Intern Med; 1988 Sep; 148(9):1957-60. PubMed ID: 2843138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histiocyte activation syndrome associated with EBV in children].
    Caniglia M; Elia L
    Clin Ter; 1992 Feb; 140(2):149-54. PubMed ID: 1314725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome.
    Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
    In Vivo; 2004; 18(2):101-6. PubMed ID: 15113035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
    Tosato G; Straus S; Henle W; Pike SE; Blaese RM
    J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistently high Epstein-Barr virus (EBV) loads in peripheral blood lymphocytes from patients with chronic active EBV infection.
    Maeda A; Wakiguchi H; Yokoyama W; Hisakawa H; Tomoda T; Kurashige T
    J Infect Dis; 1999 Apr; 179(4):1012-5. PubMed ID: 10068600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection.
    Shibata Y; Hoshino Y; Hara S; Yagasaki H; Kojima S; Nishiyama Y; Morishima T; Kimura H
    J Med Virol; 2006 Jun; 78(6):770-9. PubMed ID: 16628581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.
    Caligiuri M; Murray C; Buchwald D; Levine H; Cheney P; Peterson D; Komaroff AL; Ritz J
    J Immunol; 1987 Nov; 139(10):3306-13. PubMed ID: 2824604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
    J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cell-free viral DNA in fatal cases of chronic active Epstein-Barr virus infection.
    Kanegane H; Wakiguchi H; Kanegane C; Kurashige T; Miyawaki T; Tosato G
    Clin Infect Dis; 1999 Apr; 28(4):906-9. PubMed ID: 10825059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals.
    Buchwald D; Pearlman T; Umali J; Schmaling K; Katon W
    Am J Med; 1996 Oct; 101(4):364-70. PubMed ID: 8873506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric diagnoses in patients who have chronic fatigue syndrome.
    Kruesi MJ; Dale J; Straus SE
    J Clin Psychiatry; 1989 Feb; 50(2):53-6. PubMed ID: 2536690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.